Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Non-specific luminal toxins and macromolecules represent a broad pharmacological category of substances within the gastrointestinal tract that are targeted for neutralization or removal (DrugBank DB09278). This group includes a wide variety of exogenous materials, such as ingested poisons and pharmaceutical overdoses, as well as endogenous substances like bacterial toxins, inflammatory mediators, and metabolic byproducts (StatPearls NBK482294). Unlike classical drug targets such as receptors or enzymes, these entities are not specific biological molecules but rather a collection of pathogenic or toxic substrates. Drugs targeting these substances, primarily adsorbents like activated charcoal, function through physical sequestration rather than biochemical inhibition (PubChem CID 2723709). By binding these molecules within the gut lumen via Van der Waals forces and ionic interactions, these therapeutic agents prevent systemic absorption and local mucosal irritation. This mechanism is essential for the emergency treatment of acute intoxications and the management of various diarrheal diseases (WHO Model List of Essential Medicines). Consequently, the target is defined by the physical-chemical properties of the substances being adsorbed rather than a specific genetic or proteomic sequence.
Physical adsorption and sequestration of toxins and macromolecules within the gastrointestinal lumen to prevent their absorption or local activity.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Non-specific luminal toxins and macromolecules.